Pfizer CEO Albert Bourla joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S.

Albert Bourla and other healthcare CEOs talked about the efficacy of vaccines and how public health could take a big turn for ...

Of the 24 analysts covering Pfizer, 11 have a “Strong Buy” rating while 12 rate it as a “Hold” or some equivalent. One ...

Pfizer Chairman and CEO Albert Bourla did not mince his words at the 43rd annual J.P. Morgan Healthcare Conference in San Francisco on Monday regarding the controversial positions that Robert F.

“Albert Bourla is very proud of his Greek heritage and of his Jewish heritage, from Thessaloniki,” the Israeli prime minister said. (JTA) — Israel’s government has signed an agreement with ...

It’s not just the tech billionaires descending on Washington. Plenty of chief executives from other industries are also ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Riley Wealth Management chief market strategist Art Hogan discusses whether the Fed's interest rate move changed his investment focus on 'The Claman Countdown.' Euro Pacific Capital chief economist ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...

Two former Pfizer executives drawn into a campaign by activist investor Starboard Value to shake up the company have withdrawn their support for the plan. Pfizer's ex-chair and chief executive Ian ...

Dealmaking, deregulation and threats to global trade are expected to dominate the conversation among executives gathering in Davos this week, as Donald Trump’s return to the White House shifts the ...